NCT04253223 2021-06-11
A Study to Determine Safety and Efficacy of (REMD-477) in Controlling Hyperglycemia Due to Copanlisib
Duke University
Phase 1 Terminated
Duke University
Washington University School of Medicine
M.D. Anderson Cancer Center
Children's Hospital Los Angeles
Rutgers, The State University of New Jersey